Abstract:It is controversial whether vascular abnormalities participate as pathogenic factors during the development and maturation of aged-associated diseases that trigger mild cognitive impairment (MCI) and eventual conversion to AD. We studied the cellular and subcellular features of vascular lesions including vascular content, vasoactive substances immunoreactivity and mitochondria in brain vascular wall cells and in hippocampal neurons from human AD and animal models that mimic AD or MCI. In situ hybridization, using mitochondrial DNA (mtDNA) probes for human wild type, 5kb deleted and mouse mtDNA, was performed in conjunction with immunocytochemistry using antibodies against AbPP, 8-hydroxyguanosine (8OHG), all three isoforms of NOS and cytochrome c oxidase (COX). We found a higher degree of amyloid deposition in the vessels with more severe lesions which are immunopositive staining for AbPP and iNOS and possessed large, lipid-laden vacuoles in the cytoplasm of endothelial cells. Significantly more mitochondrial abnormalities were seen in microvessels, where lesions occurred, in human AD specimens, YAC, ApoE4 and C57B6/SJL Tg (+) mice, 2 vessels occluded aged rats and old aged rats without selective mitochondrial antioxidants (Lipoic Acid and ALCAIR) treatment. In situ hybridization, using wild type and chimera (recognizing mtDNA with the 5 kB deletion) mtDNA probes, revealed positive signals in the damaged mitochondria from the vascular endothelium and in perivascular cells of lesioned microvessels in human AD, YAC, ApoE4 and C57B6/SJL Tg (+) mouse and rats subjected to the long term CBH occlusion tissues. This damage was proximal to regions of large amyloid deposition. These mtDNA deletions were associated with increased amounts of immunoreactive AbPP, 8OHG and COX but not eNOS in the same cellular and subcellular compartments. The mtDNA deletion and expression of oxidative stress markers in vascular wall cells of these brains indicates that energy deficiency and oxidative stress, in AD, selectively affects the brain vascular tree and whole populations of vulnerable neurons. Future studies that examine the importance of mitochondrial pathophysiology in different cellular compartments may provide important insight not only into neurodegenerative and/or cerebrovascular disease pathobiology but may provide treatment targets of these conditions.

Membrane Aging As the Real Culprit of Alzheimer’s Disease: Modification of a Hypothesis

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Hydroxyurea-induced membrane fluidity decreasing as a characterization of neuronal membrane aging in Alzheimer's disease

Glucose Metabolism, Neural Cell Senescence and Alzheimer's Disease

Mitochondrial Dysfunction in Microglia: a Novel Perspective for Pathogenesis of Alzheimer’s Disease

Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer’s astrocytes

Ketone Bodies Metabolism and Alzheimer'S Disease

Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer’s disease

[P‐074]: the Primary Pathogenetic Role of Vascular Contains Vasoactive Substances, Hypoperfusion, Mitochondria Failure and Oxidative Stress in Aging and Alzheimer Disease

Metabolism: A Novel Shared Link Between Diabetes Mellitus and Alzheimer’s Disease

Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease

Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease

Decoding Alzheimer's Disease from Perturbed Cerebral Glucose Metabolism: Implications for Diagnostic and Therapeutic Strategies

Microvascular Alterations in Alzheimer's Disease

Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer’s Disease—Therapeutic Aspects

Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD+/NADH Redox Sites

Mitochondrial damage-induced abnormal glucose metabolism with ageing in the hippocampus of APP/PS1 mice

The alteration and role of glycoconjugates in Alzheimer's disease

White Matter Injury, Cholesterol Dysmetabolism, and APP/Abeta Dysmetabolism Interact to Produce Alzheimer’s Disease (AD) Neuropathology: A Hypothesis and Review

Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer's disease

Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease